Thoracic Mobilization for Restrictive Lung Disease
A Randomized Controlled Trial Comparing the Effects of Thoracic Mobilization and Conventional Respiratory Therapy on Cough Capacity, Dyspnea, and Pulmonary Function in Patients With Restrictive Lung Disease
1 other identifier
interventional
24
1 country
1
Brief Summary
This study aims to investigate the immediate effects of thoracic mobilization techniques on cough capacity, dyspnea, and pulmonary function in patients with restrictive lung disease. The intervention will be applied in a single session, and outcomes will be measured before and after the intervention to evaluate short-term physiological changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2025
CompletedStudy Start
First participant enrolled
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedJune 10, 2025
June 1, 2025
5 months
May 22, 2025
June 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary function test
Pulmonary function will be assessed using a standard spirometry test, including FVC and FEV1. The test will be conducted by a trained technician according to ATS/ERS guidelines to evaluate respiratory function.
Immediately before and immediately after intervention on Day 1
Secondary Outcomes (2)
Cough peak flow
Immediately before and immediately after intervention on Day 1
Dyspnea
Immediately before and immediately after intervention on Day 1
Study Arms (2)
Thoracic mobilization group
EXPERIMENTALParticipants receive thoracic mobilization techniques
conventional therapy group
ACTIVE COMPARATORParticipants receive conventional respiratory therapy
Interventions
Participants in this group will receive thoracic mobilization techniques in addition to conventional respiratory therapy. Thoracic mobilization will be delivered by a licensed physical therapist using passive manual techniques targeting the thoracic spine and rib cage to improve chest wall mobility and respiratory function.
Participants in this group will receive conventional respiratory therapy, including diaphragmatic breathing, pursed-lip breathing, and chest expansion exercises. The therapy will be administered by a licensed physical therapist following standard pulmonary rehabilitation protocols.
Eligibility Criteria
You may qualify if:
- Age 19 years or older
- Currently receiving respiratory therapy at C Hospital in Sejong City
- Pulmonary function test indicating restrictive pattern: FVC \< 80% and FEV1/FVC ≥ 70%
- FVC above the lower limit of normal (LLN) for age and sex
- Diagnosed with restrictive lung disease, such as idiopathic pulmonary fibrosis, scoliosis, or neuromuscular disorders (e.g., myopathy, amyotrophic lateral sclerosis)
You may not qualify if:
- FEV1/FVC ratio \< 70%
- Evidence of airway obstruction on pulmonary function testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chungnam National University Sejong Hospital
Sejong, 30099, South Korea
Related Publications (1)
Kelzuyuki, T., Noriko, S. The immediate effect of chest mobilization tech. in patients of COPD. The Journal of Japanese Physical Therapy Association.(JPTA). 2007;34(2): 20070420.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to group assignment to minimize detection bias during post-intervention evaluations
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2025
First Posted
June 10, 2025
Study Start
June 9, 2025
Primary Completion
November 18, 2025
Study Completion
December 26, 2025
Last Updated
June 10, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- IPD and supporting documents will be available beginning 6 months after publication of the primary results and will be accessible for up to 2 years.
- Access Criteria
- De-identified individual participant data and supporting documents will be available to qualified researchers for academic purposes. Requests must include a methodologically sound proposal and will be subject to approval by the study team. Data will be shared through secure institutional data transfer.
De-identified individual participant data (IPD) will be shared upon reasonable request for academic purposes. Data will be available from 6 months after publication of the primary results for a period of 2 years.